Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PDSB will decline by -45.94% over the next 2 Weeks and hit $0.32 by Tuesday, September 29, 2026. In that time frame, PDSB's share price is expected to range between $0.13 and $0.52.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 29, 2026 | 0.13 | 0.32 | 0.52 |
| Sep 28, 2026 | 0.15 | 0.33 | 0.52 |
| Sep 25, 2026 | 0.22 | 0.39 | 0.59 |
| Sep 24, 2026 | 0.19 | 0.39 | 0.58 |
| Sep 23, 2026 | 0.19 | 0.38 | 0.58 |
| Sep 22, 2026 | 0.20 | 0.40 | 0.60 |
| Sep 21, 2026 | 0.22 | 0.42 | 0.61 |
| Sep 18, 2026 | 0.30 | 0.48 | 0.67 |
| Sep 17, 2026 | 0.29 | 0.48 | 0.68 |
| Sep 16, 2026 | 0.27 | 0.47 | 0.65 |
PDSB shares rose +46.65% in Tuesday, September 15, 2026's trading session, rising from a previous close of $0.40 to move at $0.59. The stock demonstrated notable intraday movement (see PDSB's key stats for a full breakdown), fluctuating between $0.41 and $0.76, a +82.88% trading range. While recent weeks have seen some volatility, PDSB has managed to secure a +186.91% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 370.23M shares changing hands, 291.31M more than the previous session. This amounted to $216.69M in total market activity.
Will PDSB Continue Its Downward Trend?
According to analyst ratings and projections for PDSB, PDS Biotechnology Corporation shares are anticipated to decrease by -13.63%, potentially reaching $0.52 per share by September 29, 2026. Short-term technical indicators for PDSB currently suggest a bearish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the PDSB stock forecast, now is not the best time to buy PDSB stock because its current trading price is +84.99% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on PDSB covering social and institutional perspectives.
PDSB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PDSB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 61.69% to 84.34%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 48.82%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.45%, maintains a neutral outlook for the long term. Insights into PDSB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
PDS Biotechnology Short-Term Forecasts
PDSB Forecast For Next 5 Days
Our algorithm anticipates PDS Biotechnology (PDSB) stock could hit $0.32 by Sep 22, 2026. This represents a -45.17% fall from today's price, following a -3.48% change over the past five days.
PDSB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for PDS Biotechnology Corporation (PDSB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.25, which would mean a -57.29% decrease from the current price of $0.59. Projections for this period range from a high of $0.51 to a low of $0.01.
PDSB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for PDS Biotechnology's price over the next three months point to a rise. PDSB stock is expected to peak at $2.83 on Nov 11, 2026 before potentially dipping to $1.41 on Dec 07, 2026. On average, PDSB is likely to trade around $2.08 in the coming 90 days.
PDS Biotechnology Stock Forecast 2025
Based on our predictive models, PDS Biotechnology (PDSB) is expected to trade between $1.41 and $2.83 throughout 2026. This would result in an average price of $2.06, potentially offering investors a +251.96% return from current levels.
PDS Biotechnology Corporation Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, PDS Biotechnology Corporation (PDSB) is positioned to show a strong performance in September 2026. The price is predicted to move between $1.65 and $2.26, settling at an average of $1.89. This could translate to a +222.91% gain.
October 2026
Based on current market signals, PDS Biotechnology Corporation is projected to trend october 2026. We forecast a trading range from $1.99 to $2.49, with a likely average price of $2.21. Investors could expect a potential return of +277.58%.
November 2026
Our predictive algorithms indicate PDS Biotechnology Corporation stock may see a shift in November 2026. The expected range spans $1.60–$2.83, with an average target of $2.27. This represents a positive outlook and a possible gain of +287.84%.
December 2026
Analyzing established trends, PDS Biotechnology Corporation looks set to move in December 2026. Projections place the stock between $1.41 and $2.07, averaging around $1.80. This suggests a +207.53% gain from current levels.
January 2027
Market indicators suggest PDS Biotechnology Corporation could experience notable changes during January 2027. Prices could fluctuate within $1.39 to $2.00, with a midpoint forecast of $1.83. The stock might deliver a +212.66% gain.
February 2027
Forecasting for February 2027, models estimate that PDS Biotechnology Corporation may undergo key fluctuations. If trends hold, the stock might trade between $1.12 and $1.96, averaging $1.68. This signals a positive trajectory with potential returns around +187.03%.
March 2027
According to our latest forecast models, PDS Biotechnology Corporation (PDSB) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.93 and $2.20, settling at an average of $2.11. This could translate to a +260.50% gain.
April 2027
Based on current market signals, PDS Biotechnology Corporation is projected to trend april 2027. We forecast a trading range from $0.38 to $1.57, with a likely average price of $1.48. Investors could expect a potential return of +152.86%.
May 2027
Our predictive algorithms indicate PDS Biotechnology Corporation stock may see a shift in May 2027. The expected range spans $0.15–$1.40, with an average target of $1.64. This represents a positive outlook and a possible gain of +180.20%.
June 2027
Analyzing established trends, PDS Biotechnology Corporation looks set to move in June 2027. Projections place the stock between $0.00 and $1.21, averaging around $1.49. This suggests a +154.57% gain from current levels.
July 2027
Market indicators suggest PDS Biotechnology Corporation could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $0.78, with a midpoint forecast of $1.31. The stock might deliver a +123.82% gain.
August 2027
Forecasting for August 2027, models estimate that PDS Biotechnology Corporation may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.61, averaging $1.51. This signals a positive trajectory with potential returns around +157.99%.
September 2027
According to our latest forecast models, PDS Biotechnology Corporation (PDSB) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $0.31, settling at an average of $1.36. This could translate to a +132.36% gain.
PDSB's history of dividends and stock splits also plays a role in long-term investor confidence.

